SCHEMBL4510066

SCHEMBL4510066

COCCNC(=O)c1cccc(/C=C/C(=O)c2c(C)[nH]c3ccccc3c2=O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.61
RAB9A P51151 5/20 0.61
JAK2 O60674 1/20 0.61
PAX8 Q06710 1/20 0.61
MAPT P10636 10/20 0.51
LMNA P02545 6/20 0.51
KMT2A Q03164 3/20 0.51
MEN1 O00255 2/20 0.51
HTT P42858 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
HDAC1 Q13547 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
FGFR1 P11362 1/20 0.42
PDGFRA P16234 1/20 0.42
FLT1 P17948 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4510071 1.00 NPC1 (0.61) NPC1RAB9AJAK2PAX8MAPT
SCHEMBL2277535 0.85 MEN1 (0.49) NPC1RAB9AMAPTLMNAKMT2A
SCHEMBL2277539 0.85 MEN1 (0.49) NPC1RAB9AMAPTLMNAKMT2A
SCHEMBL4519287 0.83 KDM4E (0.50) NPC1RAB9AMAPTLMNAKMT2A
SCHEMBL4519284 0.83 KDM4E (0.50) NPC1RAB9AMAPTLMNAKMT2A
SCHEMBL13818126 0.81 ALDH1A1 (0.46) NPC1RAB9AMAPTHTTCYP1A2
SCHEMBL2280689 0.79 LMNA (0.43) NPC1RAB9APAX8MAPTLMNA
SCHEMBL2280683 0.79 LMNA (0.43) NPC1RAB9APAX8MAPTLMNA
SCHEMBL4512621 0.76 PADI4 (0.43) MAPTLMNAKMT2AMEN1CYP1A2
SCHEMBL4512628 0.76 PADI4 (0.43) MAPTLMNAKMT2AMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090143368-A1 Use of Cinnamoyl Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 US disclosed
US-20090143368-A1 Use of Cinnamoyl Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 US disclosed
US-20090143368-A1 Use of Cinnamoyl Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 US disclosed
EP-1857104-A1 USE OF CINNAMOYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2007-11-21 EP disclosed
EP-1857104-A1 USE OF CINNAMOYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2007-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143368-A1 Use of Cinnamoyl Compound COL2A1, COL1A1, SMAD2 NPC1 462/4885RAB9A 4027/4885JAK2 1876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.